Yunfeng Capital
云锋基金
Yunfeng Capital is a Chinese venture capital fund that has co-led or participated in several notable growth-stage deals in the 2020-2021 period. It jointly led the RMB 600 million Series B round for toy company Blokees in May 2021 alongside Legend Capital , and was among the investors in Flexiv's over-$100 million Series B in late 2020, which 高榕创投 reported made the general-purpose robotics company the highest single-round fundraiser globally in its sector at the time . The fund also appeared alongside Gaorong Ventures and others in rounds for EDA software firm Xinhuazhang and building-block brand Blokees during the same window . elsewhere's corpus does not contain more recent material on the firm's strategy, team, or fund size beyond these deal participations.
AI-generated — may contain errors, please verify.
Coverage
5Y News | D-Robotics Closes $150 Million Series B2 Round
The company's total Series B funding has reached $270 million.
五源资本·"D-Robotics" Raises Another $150 Million, Linear Capital Continues Backing Every Round | Linear Portfolio
Annual shipments surged 180% year over year.
线性资本·Wobrain Medical Completes Strategic Funding Round to Accelerate Global Expansion in Neurovascular Medical Technology
Completed a strategic merger to accelerate global expansion.
高榕创投·We Analyzed 1,000 LP Commitments and Found 30 Hidden Top Family Offices
They are also a microcosm of China's commercial evolution.
暗涌Waves·Multiple Innovative Companies Gain Global Recognition, Breakthroughs Achieved in Computational Biology, LiDAR, and Other Fields | Rongbao · July
Major events in July.
高榕创投·Vitaeon Therapeutics Completes $200 Million Series B Round to Develop Transformative Therapies for Aging-Related Degenerative Diseases
Transforming the treatment paradigm for age-related degenerative diseases, improving quality of life for millions of patients and families worldwide.
高榕创投·July: Seeking Vast Possibilities | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Axbio Closes Nearly $100M Series B Funding Round
Make faster, more accessible, ultra-low-cost sequencing products available to the life sciences and healthcare industries.
五源资本·Spring Comes Quietly to Guomao
For China's investment industry at this moment, the eerily quiet Guomao feels like a metaphor.
暗涌Waves·Investors in the Wheat Field
A Nerve-Ending-Style Descent into the Investment World: Into the Fields and Countryside.
暗涌Waves·November: Foresight and Boundless Imagination | 5Y News Monthly
The big news from last month.
五源资本·5Y News | Xpeng Motors announces completion of over $500 million Series A funding round
This marks the largest single funding round to date in Asia's low-altitude manned aircraft sector.
五源资本·Rongbao · May | Pinduoduo Enters the Era of 800 Million Users, Waterdrop Inc. Debuts on the NYSE
Meeting the needs of China's vast user base for a better life.
高榕创投·Blokees Closes RMB 600 Million Series B, Chinese Original Building-Block Brand Keeps Building Momentum
Build a global children's brand born from Chinese creativity.
高榕创投·Xinhuazhang announced the completion of a Pre-B funding round exceeding 400 million yuan, and will soon release the first-phase research results of EDA 2.0
Boost the overall efficiency of the integrated circuit industry chain to fully underpin future digital development.
高榕创投·The Best Is Always Ahead | 5Y News Monthly
Happy Labor Day!
五源资本·5Y News | CloudWalk Group Closes $600 Million Series C2 Round to Expand Global Digital Supply Chain Services
A world-class supply chain that belongs to Chinese retail.
五源资本·Gaorong Bulletin · December | Multiple Gaorong Ventures Portfolio Companies Secure New Funding in Chips, Robotics, AI Drug Discovery, New Brands, and Other Sectors
Stepping into 2021.
高榕创投·General-purpose intelligent robotics company Flexiv completes over $100 million Series B funding round
Gaorong Ventures led the investment in Flexiv in early 2019 and continued to increase its stake in subsequent funding rounds.
高榕创投·Morningside-backed LifeTech Scientific raises over RMB 1.2 billion in new funding round | Light Moments
China's new drug R&D is undergoing a "Cambrian explosion." The industry's underlying infrastructure for pharmaceutical innovation is one of the core sectors we're tracking in healthcare.
五源资本·
